University of California San Francisco

Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting.

Bhatia N, Heim J, Vasquez JG, Bhutani T, Schenkel B, Gogineni R, Koo J PMID: 39038815

The genetic evolution of acral melanoma.

Wang M, Fukushima S, Sheen YS, Ramelyte E, Cruz-Pacheco N, Shi C, Liu S, Banik I, Aquino JD, Sangueza Acosta M, Levesque M, Dummer R, Liau JY, Chu CY, Shain AH, Yeh I, Bastian BC PMID: 39034322

The genetic evolution of acral melanoma.

Wang M, Fukushima S, Sheen YS, Ramelyte E, Cruz-Pacheco N, Shi C, Liu S, Banik I, Aquino JD, Sangueza Acosta M, Levesque M, Dummer R, Liau JY, Chu CY, Shain AH, Yeh I, Bastian BC PMID: 39034322

The genetic evolution of acral melanoma.

Wang M, Fukushima S, Sheen YS, Ramelyte E, Cruz-Pacheco N, Shi C, Liu S, Banik I, Aquino JD, Sangueza Acosta M, Levesque M, Dummer R, Liau JY, Chu CY, Shain AH, Yeh I, Bastian BC PMID: 39034322

Genital calcinosis cutis: Microscopic evidence supporting a dystrophic origin.

Crockett JL, Copp HL, Mully TW, Francois RA, Cordoro KM PMID: 38989723

Genital calcinosis cutis: Microscopic evidence supporting a dystrophic origin.

Crockett JL, Copp HL, Mully TW, Francois RA, Cordoro KM PMID: 38989723

Limited English proficiency is associated with access barriers to isotretinoin for acne.

Choe J, Yan A, Charrow A, Mostaghimi A, Shiboski S, Chang AY, Barbieri JS PMID: 38990267

Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study.

Tan AJ, Xia J, Glennon CM, Locascio JJ, Gabel CK, Nguyen ED, Chand S, Rrapi R, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D PMID: 38972479

Ulcerative erythematous papules and plaques on the face and lower legs of a man living with HIV: a clinicopathological challenge.

McKenzie NC, Hickey MD, De la Sancha C, Coates SJ, Leslie KS PMID: 38965065

Association of Countries' Atopic Dermatitis Burden and Sociodemographic Index with Topical Calcineurin Inhibitor Utilization.

Ushcatz I, Zhao HJ, Tadrous M, Aoki V, Chang AY, Dlova N, Merilleno ASP, Drucker AM PMID: 38959123